MARKET

ADILW

ADILW

Adial Pharmaceuticals
NASDAQ
0.0880
0.0000
0.00%
Closed 16:00 03/17 EDT
OPEN
0.0880
PREV CLOSE
0.0880
HIGH
0.0880
LOW
0.0880
VOLUME
101
TURNOVER
9
52 WEEK HIGH
0.5700
52 WEEK LOW
0.0090
MARKET CAP
--
P/E (TTM)
-0.1284
1D
5D
1M
3M
1Y
5Y
BRIEF-Adial Pharmaceuticals Provides Update On Regulatory Strategy For AD04
Reuters · 03/06 23:40
BRIEF-Adial Pharmaceuticals- On Feb 28, Got Notification From Nasdaq Granting Request For 180-Day Extension To Regain Compliance With Min Bid Price Requirement
Reuters · 03/02 12:21
BRIEF-Adial Pharmaceuticals Announces Pricing Of $0.75 Million At-The-Market Registered Direct Offering
Reuters · 02/24 15:42
BRIEF-Adial Pharma Confirms Scheduling Of Meetings With FDA, European Regulatory Agencies Reg AD04
Reuters · 02/21 14:03
BRIEF-Adial Pharmaceuticals Reports Third Quarter 2022 Financial Results And Provides Business Update
Reuters · 11/14/2022 18:27
BRIEF-Adial Pharmaceuticals Inc - On August 31, Received Written Notice From Nasdaq Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
BRIEF-Adial Pharmaceuticals Inc - On August 31, Received Written Notice From Nasdaq Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Reuters · 09/02/2022 21:28
Adial Pharmaceuticals names new executive chief
Adial Pharmaceuticals (NASDAQ:ADIL) <a href="https://seek...
Seekingalpha · 08/22/2022 20:37
BRIEF-Adial Pharmaceuticals Names Cary Claiborne As Chief Executive Officer
BRIEF-Adial Pharmaceuticals Names Cary Claiborne As Chief Executive Officer
Reuters · 08/22/2022 20:31
More
About ADILW
Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of medications for the treatment of addictions and related disorders. Its lead investigational drug product is AD04. AD04 is being developed for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist. AD04 is being designed to be used for the treatment of other addictive disorders, such as opioid use disorder, obesity, smoking, and other drug addictions.

Webull offers kinds of Adial Pharmaceuticals Inc stock information, including NASDAQ:ADILW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADILW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ADILW stock methods without spending real money on the virtual paper trading platform.